Novo Nordisk
Signals mentioning Novo Nordisk
- IPC to set uniform semaglutide quality standards as Indian generic market expands
- India’s GLP-1 market stabilises as generic semaglutide boom fades
- Healthify merges with Berry Street to build AI metabolic-health platform for US
- HealthifyMe merges with Berry Street, eyes India pharma, insurer and offline growth
- Mankind Pharma licenses Chinese insulin analogues for India launch
- Delhi HC requires Sun Pharma to secure approval before semaglutide tablet launch
- Delhi HC requires Sun Pharma to seek clearance before semaglutide launch
- Delhi HC pauses Sun Pharma’s oral semaglutide launch in Novo Nordisk patent case
- Tata Consumer readies nutrition products for India’s GLP-1 weight-loss drug users
- Cipla prioritises Yurpeak as sales nearly double, delaying semaglutide launch
- IndiaMART to double AI spend every six months to purge fake listings and accelerate buyer matching
- Pharma-nutrition tie-ups race to capture $150B GLP-1 companion market
- Novo Nordisk's Ozempic, Wegovy sales jump 40% in India after steep price cuts
- Catalyst Brands pilots CGI product imagery from Bengaluru GCC to slash photo-shoot logistics